 The role of the 1 strand in GABA A receptor function is unclear. It lies anti-parallel to the 2 strand, which is known to participate in receptor activation.
ligand-gated ion channels (pLGICs). GABA A receptors are assembled from 19 different subunits. The most common synaptic GABA A receptor is comprised of α1, β2 and γ2 subunits (Whiting et al., 1995) .
GABA A receptors have a large extracellular domain, housing the orthosteric ligand binding site, and four transmembrane (TM) domains (TM1-4), which contain binding sites for allosteric agonists and several non-competitive antagonists. TM2 lines the Cl --selective channel pore. Like most pLGICs GABA A receptors also have a large intracellular domain, mainly composed of the TM3-4 loop (Baptista-Hon et al., 2013) .
The orthosteric binding site, located at the interface between adjacent subunits (Smith & Olsen, 1995; Cromer et al., 2002) , is lined by residues within six non-continuous loops (A-F) which participate in binding (Boileau et al., 1999; Holden & Czajkowski, 2002; Wagner et al., 2004; Goldschen-Ohm et al., 2011; Tran et al., 2011) and gating (Boileau et al., 2002; Newell & Czajkowski, 2003; Venkatachalan & Czajkowski, 2008; Szczot et al., 2014) . In GABA A receptors, the primary interface contributes loops A, B and C, from the β subunit, while the complimentary interface contributes loops D, E and F, from the α subunit. These loops are contained within an anti-parallel β sandwich structure, which makes up much of the N-terminal domain.
Several pLGIC structures have recently been solved, some in the presence of agonists providing an insight into the architecture of the orthosteric binding site. A structural model of C. elegans GluCl implicates β1 strand Arg37 in glutamate binding (Hibbs & Gouaux, 2011) . This led to the proposal of a seventh binding loop, termed loop G. However, the equivalent β1 strand residue in A. californica GluCl (Leu79) is not involved in its binding to glutamate or other amino acid agonists including GABA, suggesting that a role for the β1 strand in agonist binding may be restricted to the C. elegans GluCl (Blarre et al., 2014) . Interestingly, replacement of A. californica GluCl Leu79 by Arg resulted in abolition of glutamate evoked currents, highlighting the importance of amino acids in the β1 strand to receptor function. A comparison of GluCl structures in presumed open and closed conformations reveals that the β1 and β2 strands, as well as the β1-β2 loop, move towards the TM2-3 loop during gating (Althoff et al., 2014) . This movement appears to precede the structural rearrangement of the TM domains that allow channel opening (Calimet et al., 2013) . A similar conformational change has also been described in the recent structures of a zebrafish glycine receptor derived by cryo-electron microscopy (Du et al., 2015) .
Residues in the β1 strand of the recently solved GABA A β3 homopentamer structure are not implicated in binding its agonist, benzamidine (Miller & Aricescu, 2014) . However, residues in loop D of the anti-parallel β2 strand are, and this region of the 1 subunit lies within the GABA binding pocket in 122 GABA A receptors (Boileau et al., 1999; Holden & Czajkowski, 2002) . Furthermore, the loop D residue Phe64 participates in gating (Szczot et al., 2014) . The use of the substituted Cys accessibility method (SCAM) revealed a series of β2 strand residues within loop D that are accessible within the binding pocket. Consistent with its role in agonist binding, residue 64 became less accessible to methanethiosulfonate (MTS) modification when receptors were activated by GABA. It is likely that residues within the 1 subunit β1 strand are also solvent accessible through the ligand binding pocket since they lie adjacent to the β2 strand. As a result, Cys substituted β1 strand residues may also be amenable to SCAM.
In this study, we first examined solvent access to the GABA A β3 homopentamer using molecular dynamics (MD) simulation. We subsequently used the simulations as a guide to investigate the functional consequences of Cys substitutions at five of the equivalent β1 strand residues in the 1 subunit of 122 GABA A receptors. The introduction of Cys at these positions enabled us to examine their accessibility in the absence and presence of receptor activation.
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Methods
Cell culture and transfection -Human embryonic kidney 293 (HEK-293) cells were maintained in Dulbecco Modified Eagle's Medium (DMEM) supplemented with 10% fetal bovine serum and 100 µg ml -1 penicillin and 100 units ml -1 streptomycin at 37 o C and 5% CO 2 . Cells were seeded at low density in 35 mm dishes for electrophysiology. Transfections were performed by calcium phosphate precipitation, using 1 µg total cDNA per dish, as described previously (Baptista-Hon et al., 2013) .
cDNAs encoding wild type (WT) and mutant mouse GABA A subunits were in the pRK5 mammalian expression vector. For heteromeric expression of GABA A α1β2γ2 subunits, a 1:1:1 transfection ratio was used. cDNA encoding enhanced green fluorescence protein (in pEGFP vector, 0.1 µg) was included to identify successfully transfected cells using fluorescence microscopy. Cells were washed with media 16 h after transfection and used after 48 to 72 h. All tissue culture reagents were obtained from Invitrogen (Paisley, UK).
Mutagenesis of GABA A α1 subunits -Single point mutations were performed by overlap extension polymerase chain reaction (PCR) (Heckman & Pease, 2007) . PCR products were digested using SmaI restriction endonuclease and ligated into pRK5 vector. All mutagenesis reactions and ligations were verified using agarose gel electrophoresis and constructs were sequenced prior to functional characterisation (Genetics Core Services, University of Dundee). All PCR and molecular cloning reagents were obtained from Fermentas (Thermo-Fisher, Loughborough, UK).
Electrophysiology -The whole-cell configuration of the patch-clamp technique was used to record GABA-evoked currents from HEK-293 cells expressing WT α1β2γ2 GABA A receptors or receptors containing Cys-substituted α1 subunits. Recording electrodes were fabricated from borosilicate glass capillaries, which when filled with intracellular solution had resistances of 1.3 -2.3 MΩ for wholecell recordings. The electrode solution contained (in mM): 140 CsCl, 2 MgCl 2 , 1.1 EGTA, 3 Mg-ATP, 10 HEPES (pH 7.4 with CsOH). The extracellular solution contained (in mM): 140 NaCl, 4.7 KCl, 1.2 MgCl 2 , 2.5 CaCl 2 , 10 HEPES, 10 glucose (pH 7.4 with NaOH). Cells were voltage clamped at an electrode potential of -60 mV. Currents were evoked by rapid application of GABA using the three-pipe Perfusion Fast
Step system (Warner Instruments, CA, USA), as described previously (Baptista-Hon et al., 2013) .
All electrophysiological data were recorded using an Axopatch 200B amplifier. Data were low pass filtered at 2 kHz, digitised at 20 kHz using a Digidata 1320A interface and acquired using pCLAMP8 software (all from Molecular Devices, CA, USA).
Substituted cysteine accessibility method (SCAM) -
The cysteine sulfhydryl-specific modifying effect of a methanethiosulfonate (MTS) reagent was determined using 2-aminoethyl methanethiosulfonate (MTSEA) or phenylmethanethiosulfonate (PhMTS; Toronto Research Chemicals, Toronto, Ontario, Canada). Unless otherwise indicated, HEK-293 cells transfected with WT or Cys-substituted subunits were exposed repeatedly to an EC 50 concentration of GABA to evoke stable baseline currents (I control ).
Freshly diluted MTSEA (up to 10 mM) was then applied episodically to cells prior to their GABA EC 50 exposure. Altered current amplitudes following MTSEA exposure reveals accessibility to sulfhyrdryl modification (I modified ). The extent of modification was measured as a percentage change:
Cells were subsequently exposed to the reducing agent dithiothreitol (DTT; 10 mM) to reverse modification by MTSEA.
Rates of MTSEA modification were measured using empirically determined concentrations of MTSEA, which produced cumulative changes in the amplitude of GABA-evoked currents that reached steady state within the duration of the recording. MTSEA was applied episodically for intervals between 0.1 s and 2 s, prior to a challenge with EC 50 GABA. In all cases, the steady-state current amplitude reached that of I modified when a saturating concentration of MTSEA was used, indicating that the modification reaction had reached completion. To determine whether the rate of MTSEA modification of the substituted cysteine can be altered in the presence of agonists or allosteric agonists, a maximal concentration of GABA (EC 100 ), or an activating concentration of propofol (10 µM) was simultaneously applied with MTSEA.
MD simulations -MD simulation was carried out with the Gromacs simulation software version 4.67 (Pronk et al., 2013) . The ambersb99_ildn force field (Hornak et al., 2006; Lindorff-Larsen et al., 2010) for amino acids and the Berger force field for POPC lipids (Berger et al., 1997) were applied.
Temperature and pressure were kept constant at 298 K and 1 bar, using the v-rescale thermostat (Bussi et al., 2007) and the Parrinello-Rahman barostat (Parrinello & Rahman, 1981) with coupling constants of 0.5 ps and 2 ps, respectively. Electrostatic interactions were computed using the Particle Mesh Ewald (PME) method with a real space cut-off of 12 Å. Van der Waals (VdW) interactions were calculated using a cut-off of 12 Å. The LINCS algorithm (Hess et al., 1997) was applied to constrain all bonds. Virtual sites (Feenstra et al., 1999) were employed for hydrogen atoms permitting us to use a simulation timestep of 5 fs. We simulated two receptor/membrane systems. The total sampling time was 1.64 µs.
pK a values of all titrable groups of the GABA A 3 homopentamer (PDB-ID: 4COF) (Miller & Aricescu, 2014) were calculated using the H++ webserver (Anandakrishnan et al., 2012) and checked manually.
The transmembrane domain of the protein was first aligned to a POPC bilayer, using the program LAMBADA (Schmidt & Kandt, 2012) and slightly moved manually to match protein-lipid interactions (Contreras et al., 2011) . The protein was inserted into the membrane, employing the program InflateGRO2 (Schmidt & Kandt, 2012) . A NaCl concentration of ~180 mM was added and additional counter ions were introduced to neutralize the simulation system.
Data analysis -The peak amplitudes of agonist-evoked currents were measured using Clampfit10 Where τ f and τ s represent the fast and slow time constants, respectively. A f and A s represent the proportion of the fast and slow components, respectively, such that A f and A s sum to 1 -plateau.
Rate of MTSEA modification are provided as weighted τ (τ w ) values, calculated using:
Pseudo first-order rate constants were derived from a modified single or double exponential fit to peak current amplitude data following MTSEA applications. The double exponential function is defined by:
Where K f and K s represent the fast and slow first-order rates, respectively. A f and A s represent the proportion of the fast and slow components. Since all amplitude data are normalised to I GABA at t = 0, A f and A s sum to 1 -plateau. Second-order rate constants were obtained by dividing K by the concentration of MTSEA used (Holden & Czajkowski, 2002) .
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The solvent accessible surface area (SASA) was calculated as described previously (Eisenhaber et al., 1995) using data from the MD simulations. The solvent accessible area was graphically represented using trj_cavity (Paramo et al., 2014) . All figures containing molecular information were produced with VMD (Humphrey et al., 1996) .
Statistics -Data are presented as mean ± S.E.M. or S.D. as indicated. Differences in means of three or more groups were compared using one-way analysis of variance (ANOVA), with a post hoc Tukey or Dunnet's test, as appropriate. Pairwise comparisons were performed using the student t-test. In all cases P < 0.05 was considered statistically significant. Statistical analyses were performed using GraphPad Prism 5 (GraphPad Software, San Diego, California, U.S.A.).
Results

Residues in the β1 strand of the β3 homopentamer are solvent accessible
Changes in the accessibility of residues during GABA A receptor activation have been determined using SCAM (Boileau et al., 1999) . Two criteria are required for successful SCAM. First, the substituted Cys must be solvent accessible and second it must participate in a receptor function that is affected by modification. Both of these criteria apply to the GABA A receptor α1 subunit β2 strand loop D residue at position 64. This residue is solvent accessible and its modification by MTS reagents led to a reduction in GABA-evoked current amplitudes in receptors harbouring the α1 (F64C) substitution (Boileau et al., 1999) . Phe64 participates in GABA binding and efficacy (Boileau et al., 1999; Szczot et al., 2014) . While residues in the β1 strand do not participate in agonist binding to the GABA A β3 homopentamer structure, we examined whether they are likely to be accessible through the binding pocket (Miller and Aricescu, 2014) . We performed MD simulations of the whole protein but focused our analysis on residues located within the β1 strand of the β3 homopentamer (Fig. 1A ).
Our simulations reveal that a number of residues in the β1 strand of the GABA A  3 homopentamer are solvent accessible. A representative snapshot of the access pathways of water to the agonist binding site observed in the simulations is shown in Figure 1B . Consistent with previous reports, the critical β2 strand loop D residue, equivalent to 64 in the α1 subunit, which is Tyr62 in the β3 homopentamer, is also accessible. We quantified the solvent accessible surface area (SASA) for these residues (Fig. 1C) . The SASA values for residues from 41 to 45 are characteristic of a β-strand structure with an alternating pattern of accessibility. While residues Asn41, Asp43 and Ala45 display significant solvent accessibility, Ile42 and Ile44 are inaccessible. The number of water molecules observed to be in contact with the residues throughout our simulations agrees well with their SASA (data not shown). Other residues, e.g. Cys37, Ser46, Asp48, Met49 and Ser51 also have significant SASA values and may therefore be accessible. However, inspection of the model reveals that the highly accessible Cys37 and Met49 are located outside the binding pocket at the surface of the receptor and within the outer vestibule, respectively. Furthermore, in the β3 homopentamer model, the β1 strand has a sharp kink after residue 45, dipping towards the vestibule.
1 strand residues influence the apparent potency of GABA Our MD simulations ( Fig. 1 ) suggest that several residues within the β1 strand of GABA A receptors are part of a solvent accessible pocket contiguous with the ligand binding domain. We investigated the functional consequences of individual Cys substitutions from Asp43 to Thr47 in the α1 subunit.
These residues are homologous to those between Asn41 and Ala45 in the GABA A β3 homopentamer according to our sequence alignment (Fig. 1A ). For comparison, we also included Cys-substituted Phe64 in loop D of the β2 strand in our analysis. WT or Cys substituted α1 subunits were transiently expressed in HEK-293 cells with β2 and γ2 subunits. Representative examples of GABA-evoked currents mediated by Cys substituted GABA A receptors are shown in Figure 2A . GABA concentrationresponse relationships are plotted in Figure 2B . Logistic functions fitted to the data reveal rightward shifts in the GABA concentration-response relationship for some Cys-substituted receptors. The average best-fit parameters derived from logistic functions fitted to data recorded from several different cells are summarised in (Table 1) . Like 1(F64C)22, both 1(D43C)22 and 1(T47C)22
receptors had reduced GABA-evoked peak current densities compared to WT which were statistically significant (P < 0.0001 and P < 0.05 respectively; one-way ANOVA with post hoc Dunnet's comparison with 122 receptors; Table 1 ). The Cys substitution in 1(F45C)22 receptors produced more complicated changes in function described in the following section.
The 1 F45C substitution causes a biphasic GABA concentration-response relationship and spontaneous gating
The GABA concentration-response relationship for 1(F45C)22 receptors is shown in Figure 3A 3A ). An F-test applied to statistically discriminate between the two approaches revealed that the two-component logistic function provided a significantly improved fit to the data (P = 0.025). The solid grey lines in Figure 3A illustrate the two components of the GABA concentration-response relationship. The logistic fit for WT 122 receptors is also reproduced here (dashed grey line) for comparison. Table 1 contains the values derived from the two-component logistic function consistent with high and low apparent potency components for GABA-evoked activation of
GABA A receptors with high levels of spontaneous gating generally have a higher sensitivity to GABA (Mortensen et al., 2003; Hadley & Amin, 2007) . The high apparent potency component of GABA activation of 1(F45C)22 receptors may therefore be associated with spontaneous activity. We investigated the possibility of spontaneous gating by recording the inhibition of basal currents by picrotoxin (PTX) in WT 122 and 1(F45C)22 receptors. Figure 3B shows representative examples of maximally effective GABA-evoked currents (grey trace) and inhibition of basal currents by PTX (black trace). WT 122 receptors display very little PTX inhibited basal current (Fig. 3B inset). By comparison, the magnitude of PTX inhibited basal current in 1(F45C)22 receptors was large ( Fig. 3B inset) . We quantified spontaneous current as the magnitude of the PTX component (I PTX ) as a percentage of the total amount of current (I GABA + I PTX ). The maximum GABA-evoked current densities in WT 122 and 1(F45C)22 receptors did not differ significantly (Table 1) . Therefore it is unlikely that the maximum efficacy of GABA is altered by the F45C substitution. The mean I PTX /I total values are shown in Figure 3C . 1(F45C)22 receptors had an increased proportion of spontaneous current from 0.05 ± 0.02% (n = 5) in WT 122 receptors to 0.52 ± 0.11% (n = 10). The difference was statistically significant (P = 0.014; t-test). These data suggest that F45C substitution increased spontaneous gating and therefore Phe45 in the β1 strand plays critical and complex roles in GABA A receptor function.
Several residues in the 1 strand of the GABA A α1 subunit are accessible to MTSEA modification β1 strand residues in the GluCl  subunit (Hibbs & Gouaux, 2011) and GABA A β3 homopentamer (Miller & Aricescu, 2014 ) models have side-chains facing into the orthosteric binding pocket. Our MD simulation data demonstrate that residues in the GABA A β3 homopentamer, equivalent to amino acids 43 -47 in the 1 subunit, are solvent accessible (Fig. 1C) . Furthermore, receptors containing 1 subunit D43C, F45C, T47C substituents all exhibit functions distinguishable from WT receptors (Figs 2 and 3 and Table 1 ). Therefore, 1 subunit 1 strand residues may be accessible to MTS reagents and their modification may alter function.
We used SCAM to investigate whether the substituted cysteine residues in the β1 strand of the containing GABA A receptors (Boileau et al., 1999; Holden & Czajkowski, 2002) . We adapted the technique for use in whole-cell patch-clamp recordings from HEK-293 cells using rapid application of GABA and MTSEA (see Methods), and used 1(F64C)22 receptors for comparison.
We first tested whether MTSEA (10 mM) modulates GABA A receptors containing WT α1 subunits (Fig.   4A ). Control currents were evoked by an EC 50 concentration of GABA (10 µM) in HEK-293 cells expressing α1β2γ2 GABA A receptors. Modification by MTSEA (10 mM) was tested by pre-application for 2 s prior to GABA. Five applications were tested, such that cells were exposed to MTSEA cumulatively for 10 s. The amplitudes of GABA-evoked currents appeared modestly enhanced following MTSEA treatment in some cells, but the mean did not significantly differ from that of controls (n = 6). We next confirmed that MTSEA (2 mM) modifies the function of1(F64C)22
receptors. MTSEA substantially reduced the current amplitude evoked by an EC 50 concentration of GABA (10 mM; Fig. 4A ). The application of the reducing agent DTT (10 mM) reversed the modification by MTSEA. This result is consistent with a previous report of the effects of SCAM on GABA A receptors containing the1(F64C) subunit (Boileau et al., 1999) .
Using the same approach, we applied MTSEA (10 mM) to GABA A receptors containing Cyssubstituted β1 strand residues. Exemplar currents evoked by an EC 50 concentration of GABA before and after MTSEA application are shown in Figure 4B . MTSEA application caused a reduction in GABAevoked current amplitude in1(D43C)22 and 1(T47C)22 receptors. MTSEA did not affect the amplitude of 1(I44C)22, 1(F45C)22 or 1(V46C)22 receptors. The equivalent residues to Cys44 and Cys46 in the GABA A β3 homopentamer showed low SASA values and the failure of MTSEA to affect function is consistent with their lack of solvent accessibility (Fig. 1C) .
It is interesting that 1(F45C)22 receptors were unaffected by MTSEA despite a high SASA (Fig. 1C) and the importance of the identity of this residue in receptor function (Fig. 3) . It is possible that modification by MTSEA, which would add a positive charge to the Cys residue, was functionally silent in these receptors. We therefore used a different sulfhydrl modifying reagent, phenylmethanethiosulfonate (PhMTS) which adds an aromatic group to an accessible Cys, a modification that would mimic the native Phe. However, PhMTS (200 µM) applied for over 2 min also had no effect on the function of 1(F45C)22 receptors (data not shown). In addition, we repeated the MTSEA experiment on 1(F45C)22 receptors using 1 mM GABA as the test concentration. The effect of 1 mM GABA was maximal at WT 122 receptors (Fig. 2C ), whereas this concentration was only 80% effective at 1(F45C)22 receptors (Fig. 3A) . However, MTSEA had no effect on the amplitude of GABA (1 mM)-evoked currents (data not shown). In addition to an altered GABA concentration-response relationship, 1(F45C)22 receptors displayed higher 14 spontaneous activity compared to WT 122 receptors. We therefore examined whether MTSEA could influence the extent of spontaneous activity mediated by 1(F45C)22 receptors. Cells were treated with MTSEA (2 mM) for 2 min and spontaneous activity was measured as the percentage of I PTX to I total . Figure 4C compares I PTX /I total in control conditions and in the presence of MTSEA (2 mM).
There was no significant difference in the level of spontaneous activity in the presence of MTSEA.
Taken together, these data suggest that, while Cys43 and Cys47 are accessible to MTSEA, Cys45 is inaccessible.
We quantified the extent of MTSEA modification determining the percentage changes in EC 50 GABAevoked current amplitude for each Cys substituted receptor before and after MTSEA application.
These values are plotted in Figure 4D . Application of MTSEA caused a significant reduction in the amplitudes of GABA-evoked currents mediated by 1(D43C)22, 1(T47C)22 and 1(F64C)22
receptors relative to those mediated by WT receptors (P < 0.0001; one-way ANOVA; post hoc
Dunnet's comparison vs 122).
Receptor activation influences MTSEA modification of D43C and T47C containing receptors
Receptor activation by an agonist might influence the accessibility of a substituted Cys. This could occur as a result of the bound agonist directly protecting the residue from modification.
Alternatively activation may cause a conformational rearrangement of the receptor in which the Cys becomes less accessible. The 1(F64C) was modified more slowly by an MTS reagent applied with GABA to Xenopus oocytes expressing 1(F64C)22 receptors (Boileau et al., 1999) . We investigated whether GABA also affects the modification of 1(D43C)22 and 1(T47C)22 receptors by applying MTSEA in its presence and absence. Once again we modified the approach for use in voltage-clamped HEK-293 cells (see Methods).
First, using this approach, we compared the rate of MTSEA modification of 1(D43C)22, 1(T47C)22 and 1(F64C)22 receptors. Figure 5A shows representative examples of the effect of rapid and short applications of MTSEA on GABA-evoked currents mediated by 1(D43C)22, 1(T47C)22 and 1(F64C)22 receptors. The concentration of MTSEA used for each mutant was chosen empirically on the basis of a measurable reduction in the amplitude of the EC 50 GABA-evoked current during the time course of the experiment. For 1(D43C)22 and 1(F64C)22 receptors, MTSEA (100 µM and 10 µM, respectively) was applied episodically for 100 ms, prior to application of a test concentration of GABA (EC 50 ). For both receptors, the modification was complete within 500 ms. The rate of MTSEA (100 µM) modification of 1(T47C)22 receptors was slower and therefore MTSEA was applied episodically for 500 ms prior to the application of GABA (EC 50 ). We analysed the change in EC 50 GABA-evoked current amplitude and expressed these as a percentage of the control current. Figure 5B shows the rate of MTSEA evoked reduction of GABA-evoked currents mediated by 1(D43C)22, 1(T47C)22 and 1(F64C)22 receptors. In all cases, the time course of MTSEA modification was well fitted with a single exponential. The mean (± S.E.M.) time constants of modification are plotted in Figure 5C . One-way ANOVA with a post hoc Tukey's comparison of the time constants revealed that both 1(D43C)22 and 1(F64C)22 receptors exhibited modification time constants which were significantly smaller than that of 1(T47C)22 receptors (P < 0.0001). We also determined the second-order rate constants for MTSEA modification (see methods). Second-order rate constants are summarised in Table 2 . The second-order rate constants for 1(F64C)22 receptors were significantly faster than that of 1(D43C)22 and 1(T47C)22 receptors (P < 0.0001; one-way ANOVA; post hoc Tukey's comparison; Table 2 ). Our second-order rate constant for MTSEA modification, derived from HEK cells expressing 1(F64C)22 receptors, is similar to that reported by Holden and Czajkowski (2002) in oocytes. The plateau of modification for 1(D43C)22, 1(T47C)22 and 1(F64C)22 receptors, which indicates the maximal extent in functional change for the concentration of MTSEA tested, did not differ from those shown in Figure   4D , which used a high concentration of MTSEA (2 mM). This demonstrates that modification was complete. Our data suggest that Cys64 and Cys43 are more accessible to modification than Cys47.
We next repeated the experiment in the presence of either a maximal concentration of GABA, or an activating concentration of propofol (10 µM), applied simultaneously with MTSEA. In all cases (1(F64C)22, 1(D43C)22 and 1(T47C)22 receptors), the co-application of either GABA or propofol with MTSEA induced inward currents. Figure 6A shows the rate of MTSEA (10 µM) modification of 1(F64C)22 receptors in the presence of either GABA (300 mM) or propofol (10 µM). The rate of modification was again measured by episodic (100 ms) application of MTSEA (10 µM) with GABA (300 mM) or propofol (10 µM) for the first 500 ms. Propofol did not affect the rate of MTSEA modification (Fig. 6A inset) . In the presence of GABA (300 mM) however, the extent of modification following 500 ms of MTSEA exposure was less than in its absence (Fig. 6A inset) . We therefore increased the duration of each episodic application to 2 s. The rate of modification in the presence of GABA was best fitted with a double exponential (Fig. 6A) . The weighted τ was calculated for modification when MTSEA was applied simultaneously with GABA and compared with the τ for modification in the absence of GABA. The mean (± S.E.M.) time constants are plotted in Figure 6B .
The second-order rate constants derived from the exponential fits are summarised in Table 2 . GABA (300 mM), but not propofol (10 µM), significantly slowed the rate of MTSEA (10 µM) modification at 1(F64C)22 receptors (P = 0.0004; one-way ANOVA; post hoc Tukey's comparison). Our data are consistent with previous observations indicating that GABA, but not the allosteric agonist pentobarbital, influences modification of α1(F64C) containing GABA A receptors (Boileau et al., 1999) .
Using the same approach, we determined the effect of GABA and propofol on MTSEA (100 µM) modification of 1(D43C)22 and 1(T47C)22 receptors. The concentrations of GABA used were 300 mM and 30 mM, respectively and 10 µM propofol was used for both receptors. The time course for MTSEA modification in control, in the presence of GABA and in the presence of propofol for 1(D43C)22 receptors is shown in Figure 6D . MTSEA in the presence or absence of agonists was applied cumulatively for 100 ms. The rates of modification in all three conditions were well fitted with single exponential functions (Fig. 6D) . The mean (± S.E.M.) time constants and extent of functional change are plotted in Figure 6E and F, respectively. Second-order rate constants are summarised in Table 2 . In the presence of GABA (300 mM), there was a significant increase in the τ of MTSEA modification (P < 0.05; one-way ANOVA; post hoc Tukey's comparison vs control). There was a tendency for the τ of modification to increase in the presence of propofol, but this was not statistically significant. However, there was also no significant difference in the τ of modification in the presence of GABA and in the presence of propofol. Furthermore, comparison of the extent of functional change revealed a statistically significant reduction between that in the presence of GABA and control (P < 0.05; one-way ANOVA; post hoc Tukey's comparison vs control), and that in the presence of propofol and control (P < 0.05; one-way ANOVA; post hoc Tukey's comparison vs control; Fig. 6F ). These data therefore suggest that both GABA and propofol influence MTSEA modification of Cys43. This is in contrast to Cys64 in loop D where the allosteric agonist propofol did not influence MTSEA modification (Fig. 6A-C) . Figure 6G shows the time course of MTSEA (100 µM) modification of 1(T47C)22 receptors in control, in the presence of GABA (30 mM) and in the presence of propofol (10 µM). MTSEA in the presence or absence of agonists was applied cumulatively for 500 ms. The time course for modification in each case was well fitted with a single exponential function. The mean (± S.E.M) τ of modification and the extent of functional change are plotted in Figure 6H and I respectively. Secondorder rate constants are summarised in Table 2 . GABA (30 mM) and propofol (10 µM) did not significantly alter the τ of MTSEA modification at 1(T47C)22 receptors. However, both GABA and propofol significantly reduced the extent of MTSEA mediated inhibition (P < 0.05; one-way ANOVA;
post hoc Tukey's comparison vs control; Fig. 6I ).
Discussion
In this study, we investigated the role of the α1 subunit β1 strand in GABA A receptor function.
Guided by MD simulation data on the SASA of equivalent residues of the GABA A β3 homopentamer, we mutated five continuous residues on the β1 strand of the GABA A α1 subunit to Cys. Whole-cell voltage clamp electrophysiology revealed that D43C, F45C and T47C substitutions caused changes in the GABA concentration-response relationship, demonstrating for the first time that the β1 strand residues play a role in mammalian pLGIC function.
The β1 strand runs adjacent and parallel to the critical β2 strand, which contains loop D. A crucial Phe (Phe64) in the β2 strand of the GABA A receptor α1 subunit plays a critical role in both GABA binding and the conformational transition which leads to orthosteric gating of the channel (Boileau et al., 1999; Szczot et al., 2014) . These effects also manifest as a large rightward shift in the apparent potency for GABA. The agonist concentration-response relationship (and therefore apparent potencies) are composites of binding and gating events, and therefore both can influence the concentration-response relationship (Colquhoun, 1998) . Indeed, 1 subunit Phe64 in the 2 strand, which causes large rightward shifts in the apparent potency of GABA, when Cys substituted, is an example of a residue with a dual action in binding and gating efficacy (Boileau et al., 1999; Szczot et al., 2014) . Substituted Cys64 in the GABA A receptor 1 subunit was accessible to sulfydryl modification when expressed in Xenopus oocytes (Boileau et al., 1999; Holden & Czajkowski, 2002) .
Using fast applications of MTSEA, we showed that the same substitution in α1β2γ2 receptors expressed in HEK-293 cells was modified with a similar second-order rate constant. Furthermore, as previously reported, the presence of GABA slows the rate of Cys64 modification while the allosteric agonist propofol had no effect. This is in contrast to α1(D43C)β2γ2 and α1(T47C)β2γ2 receptors, where both GABA and propofol affect MTSEA mediated modification of the substituted Cys, suggesting that β1 strand residues play a different role to that of Phe64 in the β2 strand in terms of GABA A receptor activation.
Changes in Cys accessibility during receptor activation can be due to either direct or indirect effects of agonists. Direct agonist effects likely arise from hindrance of the substituted Cys by the bound agonist (protection), while indirect effects likely arise from conformational changes induced by the agonist which alter the position of the substituted Cys, making it less accessible. Our data show that an activating concentration of propofol impairs the accessibility of both Cys43 and Cys47 in a similar manner to a maximally effective concentration of GABA. This is consistent with a conformational change associated with gating resulting in reduced accessibility of positions 43 and 47. This also suggests that the structural rearrangements in the β1 strand of the GABA A receptor α1 subunit is similar, irrespective of agonist binding in the vicinity, or far away from the orthosteric binding site. A conformational change in this region makes sense given the anti-parallel location of the β1 relative to the β2 strand, together constituting a hairpin structure that participates in the transduction of binding to GABA A channel opening. Indeed, Kash et al (2003) implicated an interaction between the loop connecting the 1 and 2 strands of the α1 subunit, and the TM2-3 loop during GABA A receptor activation. Furthermore, we have previously demonstrated that substitution of the conserved 1 subunit TM2-3 Lys278 with methionine reduces the efficacy of activation by GABA and propofol (Hales et al., 2006) . The same mutation also reduced the level of spontaneous gating of α1(K278M)β22 GABA A receptors consistent with a global reduction in gating (Othman et al., 2012) .
Comparison of the open (ivermectin and glutamate bound) and closed (apo) structures of GluCl also reveals movement in this region associated with channel opening (Althoff et al., 2014) . During activation there is a downward displacement of the β1-β2 loop, increasing its proximity to the TM2-3
loop. The agonist bound and apo-GluCl models also reveal large movements of residues within the β1 and β2 strands, particularly Arg37 in the β1 strand, homologous to Thr47 in this study.
Comparison of the open (glycine bound) and closed (strychnine bound) structures of the zebrafish glycine receptor reveal similar movements of the β1-β2 loop (Du et al., 2015) . It is therefore becoming evident that residues along the β1 and β2 strands are well positioned to participate in the transduction of agonist binding to gating.
While α1(D43C)β2γ2 and α1(T47C)β2γ2 receptors were sensitive to MTSEA modification, α1(I42C)β2γ2, α1(F45C)β2γ2 and α1(V46C)β2γ2 receptors were not. The low SASA values of the homologous residues to those in position 42 and 46 of the GABA A β3 homopentamer (Ile42 and Ile44 respectively; Fig. 1 ) suggest that these residues are not solvent exposed, but instead have their side chains orientated within a hydrophobic environment. However, the homologous position to Cys45 in the GABA A β3 homopentamer (Asp43) is solvent accessible; this contrasts with our SCAM data which demonstrate that Cys45 is not modifiable by MTSEA or PhMTS. We propose that the carboxylate group of Asp43 (equivalent to Phe45 in α1) causes an increased hydration of the agonist binding site in the case of the β3 homopentamer, as it has previously been shown that negatively charged side chains can promote solvation even in highly hydrophobic regions (Krah et al., 2010; Villinger et al., 2010) . The structure of the α1 subunit within the heteromeric α1β2γ2 receptor may also differ significantly from the β3 subunit altering the environment of α1 residue 45 relative to the equivalent β3 residue 43. The most obvious structural difference between these two subunits in the vicinity of this residue is in loop F, which together with loop D sandwich the β1 strand. Loop F has two fewer residues in the α1 subunit compared to the β3 subunit.
Our data also demonstrate that α1(F45C)β2γ2 receptors have a biphasic GABA concentrationresponse relationship with increased spontaneous gating. The component of the biphasic GABA concentration-response relationship, with the higher apparent potency, may occur as a consequence of increased spontaneous gating observed for α1(F45C)β2γ2 relative to WT receptors. Our finding that α1(F45C)β2γ2 exhibits increased spontaneous gating suggests that residue Phe45 stabilises the receptor in the inactive conformation.
Mutations that increase spontaneous gating typically cause a left-shifted concentration-response relationship, where receptors have a higher sensitivity to agonists (Mortensen et al., 2003; Hadley & Amin, 2007) . The component of the α1(F45C)β2γ2 concentration-response relationship, with a lower apparent potency, has a shallow Hill coefficient (~0.5; Fig. 3A ; Table 1 (Khatri et al., 2009 ). Interestingly, for GABA A 1 receptors, a number of loop F Cys substitutions appeared to reduce the Hill coefficient. Loop F residues in the γ2 subunit are also implicated in transducing benzodiazepine binding events to altered gating (Hanson & Czajkowski, 2008) and it has been postulated that loop F residues play a role in cooperatively of agonist binding (Khatri & Weiss, 2010) . Therefore, Phe45 in the β1 strand of the GABA A α1 subunit may transduce structural rearrangements within the binding pocket to the adjacent binding domain, via loop F.
Therefore, the lack of Phe45 in the α1(F45C)β2γ2 receptor may lead to an uncoupling of binding between the two orthosteric binding sites. In addition, the existence of receptors in either the spontaneously open conformation or in the closed state may provide an explanation for high and low sensitivity components of the concentration response relationship.
Residues in the β1 and β2 strands of the Erwinia chrysanthemi ligand gated ion channel (ELIC) (Pan et al., 2012) and neuronal α7 acetylcholine receptors (Quiram et al., 2000) have been implicated in the recognition of antagonists. The C. elegans GluCl α subunit homopentamer is the only structure which implicates 1 strand residues in agonist binding, and consequently this region was postulated to be a seventh ligand binding loop, termed loop G (Hibbs & Gouaux, 2011) . Arg45 in the C. elegans
GluCl α subunit appears to participate in glutamate binding. By contrast, β1 strand residues of the GABA A β3 (Miller & Aricescu, 2014) , and the 5-HT 3 A receptors (Hassaine et al., 2014) , lie outside the 20 ligand binding site. Emerging structural data suggest that a direct role for β1 strand residues in agonist binding may be restricted to the C. elegans GluCl (Blarre et al., 2014) .
Our findings suggest that naturally occurring mutations and polymorphisms that affect the β1 strand may result in functional deficits that could be pathological. We are unaware of any such mutations that have been identified to date, but knowledge of the importance of this region of the receptor may prove to be important in future studies.
Refinement of the SCAM for use with rapid solution exchange should enable an investigation of altered accessibility caused by specific states of the receptor induced by agonist activation. We anticipate that this approach will help bridge the gap between static structural models and real time recordings of electrophysiology. This will help to discriminate between conformational changes caused by activation and desensitisation. (27) α1 (V46C)β2γ2 19.0 ± 4.1 (4) 1.48 ± 0.13 (4) 890 ± 230 (7) α1 ( 
